Clinical Trial

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

Name: Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma — clinical trial record (NCT05912582)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This clinical research aims to explore potential biomarkers and validate molecular signatures' predictive and prognostic value in nasopharyngeal carcinoma.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-06-21.

Trial Details

NCT Number	NCT05912582
Lead Sponsor	Jiangsu Cancer Institute & Hospital
Conditions	Nasopharyngeal Carcinoma
Enrollment	60 participants
Start Date	2025-12-25
Primary Completion	2027-06-25 (estimated)
Study Completion	2028-12-25 (estimated)
Updated on ClinicalTrials.gov	2025-12-26